In addition, imatinib exposure diminished its phosphorylation (Fig 6C). These facts counsel that in human CML-iPSCs Ph+, BCR-ABL1 phosphorylates STAT-three and this could limit the hematopoietic differentiation.Figure 5. Effect of shRNA from BCR-ABL1
As a result, the particular habits of the CML-iPSC one.31 was specifically dependent of...